Frederick C. Beddingfield III - President & CEO, Sienna Biopharmaceuticals, Inc

As of August 8, 2019


Frederick C. Beddingfield III Net Worth

  • Net worth is estimated to be at least $12.34M
  • Owns at least 944,276 units of Sienna Biopharmaceuticals, Inc stock
  • Sold an estimated value of $12.97K in the last 2 years at Sienna Biopharmaceuticals, Inc

Frederick C. Beddingfield III Trading

  • Largest purchase of shares was 40,000 units , worth over $100K on February 26, 2019
  • In total has made about 8 transactions over 2 years
  • Usually trades in August and July, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Frederick C. Beddingfield III Mailing Address

  • Mailing address is C/o Kythera Biopharmaceuticals, Inc. 27200 West Agoura Road, Suite 200 Calabasas CA 91301 CA

Sienna Biopharmaceuticals, Inc Insider Trading

  • The most recent transaction was 2,165,800 units bought on February 26, 2019 by Arch Venture Partners X Llc, Arch Venture Fund X Overage Lp, Arch Venture Partners X Overage Lp, Keith Crandell, Robert Nelsen and Steven Gillis worth over $5.41M
  • In the last 2 years, insiders at Sienna Biopharmaceuticals, Inc sold an estimated value of $1.71M and bought an estimated value of $17.81M
  • The most active traders are Todd Harris,  Frederick C. Beddingfield III, President & CEO,  and Paul F Lizzul, Chief Medical Officer
  • Insider trading is most common in August and June, with the busiest year in 2019

Sienna Biopharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1